柳叶刀·2012-June-29

柳叶刀_2012-June-29.pdfEditorial Anewmilestoneinthehistoryofcongenitalheartdisease Andrew Ewer and colleagues meta-analysis of pulse hypoplastic left heart syndrome, but also to advance oximetry screening for critical congenital heart defects the possibility of intrauterine interventions that is a cheap and readily availComment Quadsinitforantiretroviraltherapy? study teams assessed the efficacy and safety of the latest drug.Elvitegravir is metabolised mainly via CYP3A4-5, andsingle-tabletregimen—combining elvitegravir, cobicistat,which enables pharmacokinetic boosting and once- emtricitabine, and tenofovirComment Sax PE, Delesus E, Mills A, et al, forthe GS-US-236-0102 study team.Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, et al Tenofovir Co-formulated elvitegravir, cobicistat, emtricitabine, andtenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment nephro
———— 文字由OCR识别(未校验)，可能存在错字；请以原始完整版为准。